Psychiatry and Neurology, Neurology · Orlando, FL
NPI
1043284755
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6735 Conroy Rd, Suite 229
Orlando, FL, 32835
Phone (407) 581-8640
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
1,166 services
Medicare patients, 2024
390
Average age 74
Drug cost, 2024
$6.1M
32,777 prescriptions
Company payments, 2025
$16K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fernando Gonzales-Portillo was code 99214 (office e&m - established), 730 times for 323 patients. In total Fernando Gonzales-Portillo billed 1,166 services in 9 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 730 | 323 | $91.11 | $67K |
| 95886 Electrical Nerve Conductivity | Office | 136 | 57 | $73.33 | $9,973 |
| 99204 Office E&M - New | Office | 96 | 96 | $116.29 | $11K |
| 95816 Neurologic | Office | 85 | 85 | $286.01 | $24K |
| 95911 Electrical Nerve Conductivity | Office | 73 | 59 | $155.15 | $11K |
| 99223 Hospital E&M - Initial | Facility | 21 | 21 | $138.34 | $2,905 |
By year: 2022 $178K for 1,902 services; 2023 $129K for 1,446 services; 2024 $128K for 1,166 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fernando Gonzales-Portillo prescribed most often to Medicare patients was Donepezil Hcl, with 4,134 prescriptions and refills. In total Fernando Gonzales-Portillo wrote 32,777 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 4,134 | 6,693 | 1,118 | $28K |
| Gabapentin Generic | 3,455 | 4,098 | 801 | $39K |
| Memantine Hcl Generic | 2,822 | 3,847 | 611 | $54K |
| Amitriptyline Hcl Generic | 1,985 | 2,703 | 531 | $30K |
| Primidone Generic | 1,379 | 2,031 | 318 | $22K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,010 | 1,554 | 214 | $13K |
| Duloxetine Hcl Generic | 936 | 1,315 | 246 | $23K |
| Quetiapine Fumarate Generic | 899 | 1,167 | 202 | $13K |
| Benztropine Mesylate Generic | 867 | 1,276 | 187 | $13K |
| Levetiracetam Generic | 803 | 1,351 | 200 | $23K |
| Nurtec Odt Rimegepant Sulfate | 756 | 765 | 175 | $1.4M |
| Baclofen Generic | 699 | 862 | 269 | $3,377 |
| Diclofenac Sodium Generic | 660 | 687 | 196 | $5,676 |
| Tizanidine Hcl Generic | 636 | 760 | 181 | $4,469 |
| Sumatriptan Succinate Generic | 617 | 641 | 220 | $7,936 |
Brand drugs: 3,699 claims; generic drugs: 28,986 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fernando Gonzales-Portillo $16K ($16K in general payments such as food, travel and fees) from 34 companies. The largest payer was Axsome Therapeutics, Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 5 | $10K |
| Pfizer Inc. PFE | 90 | $1,132 |
| Abbvie Inc. ABBV | 42 | $518 |
| Lundbeck LLC | 39 | $516 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 33 | $453 |
| Neurocrine BioSciences, Inc. NBIX | 21 | $448 |
| Teva Pharmaceuticals USA, Inc. TEVA | 18 | $311 |
| UCB, Inc. UCB.BR | 16 | $296 |
| ACADIA Pharmaceuticals Inc ACAD | 18 | $251 |
| EMD Serono, Inc. MRK.DE | 7 | $235 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.